News

Wolfspeed Investors Alert: Important Legal Deadlines Ahead

Wolfspeed Investors Alert: Important Legal Deadlines Ahead

Wolfspeed Investors Alert: Important Legal Deadlines Ahead

As a shareholder of Wolfspeed, Inc. (NYSE: WOLF), it’s crucial to be aware of the recent developments concerning the ongoing securities fraud class action lawsuit against the company. This action raises important questions for investors who owned shares within a specified time frame.

Understanding Your Rights

If you purchased shares of Wolfspeed during the period from August 16, 2023, to November 6, 2024, you may have certain rights regarding your investment. The significant information regarding this class action raises the following questions:

Do You Own Shares of Wolfspeed?

Were you among the investors who acquired Wolfspeed securities during the aforementioned time? If so, you might have incurred loss due to the alleged misrepresentation by the company. Active participation in the lawsuit could be vital for your financial recovery.

What Does the Lawsuit Entail?

The class action lawsuit filed in the United States District Court alleges that Wolfspeed made misleading statements regarding its growth potential and profitability, particularly concerning the operational efficiency of its Mohawk Valley fabrication facility. This aspect is paramount for investors looking to understand the integrity of their investments.

Filing as a Lead Plaintiff

For those interested in taking a more active role in the litigation, the opportunity to serve as a lead plaintiff is available. However, you would need to file the necessary documents by January 17, 2025. This role allows you to represent the interests of other investors, although not participating does not forfeit your rights in any recovery that may arise from the lawsuit.

Importance of Legal Support

Bernstein Liebhard LLP, known for its commitment to investor rights, is fielding inquiries from Wolfspeed shareholders regarding their legal options. This firm has a track record of success, having recovered over $3.5 billion for its clients since its inception.

What Should You Do Next?

If you're considering your next steps as a Wolfspeed shareholder, it may be beneficial to contact an attorney who specializes in securities fraud. They can help you understand your legal standing and the potential implications of the lawsuit.

Contact Information

For more details about the lawsuit and your rights as an investor, please get in touch with:

Peter Allocco
Investor Relations Manager
Bernstein Liebhard LLP
(212) 951-2030

Frequently Asked Questions

What is the deadline to file as a lead plaintiff?

The deadline to file as a lead plaintiff in the class action lawsuit is January 17, 2025.

How do I know if I qualify as an affected shareholder?

You qualify if you purchased Wolfspeed shares between August 16, 2023, and November 6, 2024.

What kind of claims are being made against Wolfspeed?

The claims involve allegations of misrepresentation concerning the company's growth potential and the performance of the Mohawk Valley facility.

Can I participate in the lawsuit without being a lead plaintiff?

Yes, you can remain an absent class member while still retaining your rights to any potential recovery.

Who can I contact for more information?

You can contact Peter Allocco at Bernstein Liebhard LLP for assistance and more information regarding the lawsuit.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AppLovin Faces Lawsuit: Investor Unrest Unfolds

Updated Category News Views 5

Shaky Ground Beneath AppLovin's Feet Ah, the sweet smell of litigation in the tech space—it’s like déjà vu for seasoned market folks. Here we have AppLovin, nestled comfortably in San Francisco, now eying a saucy class-action lawsuit. We're looking at shareholders taking a firm stance against some arguably misleading claims. We're talking big deals with allegations...

Continue Reading
ACLM and eClinicalWorks Expand Lifestyle Medicine Reach

Updated Category News Views 74

Changing the Game with Lifestyle Medicine When it comes to healthcare, you're always going to have the skeptics grousing about the old ways. But what happens when you take an old idea and turbocharge it with modern tech? That's where the American College of Lifestyle Medicine (ACLM) and eClinicalWorks step in. They’re throwing a new wrench into the electronic health...

Continue Reading
ZBS Group Takes Over Rabinowitz’s CPA Practice with Bold Moves

Updated Category News Views 25

Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....

Continue Reading
SWFI's I20 Summit Spotlights 3,000 Promising Start-Ups

Updated Category News Views 42

Spotlight on Emerging Titans: The Future 100 Watchlist The Sovereign Wealth Fund Institute is rattling the investment cages with their latest stunt, the 'Future 100 Watchlist.' Hot off the press, this list is parading nearly 3,000 start-ups that are biting at the heels of future success. It's high stakes and higher hopes between December 11-16 at Miami's I20 Summit, where...

Continue Reading
Artprice Bridges Art and AI Across the Hispanic World

Updated Category News Views 11

A Monumental Launch with Deep Roots I've been around long enough to see all sorts of moves in the art world and the tech world. But what Artprice by Artmarket is pulling off here—it’s a doozy. Thierry Ehrmann’s “Diálogo entre un pensador y la IA” just went live in Spanish, and that’s not some paperback thrill ride. We’re talking about an 1,800-page piece of...

Continue Reading
Tulsa Hosts Gradient's Global Tech and Investment Event

Updated Category News Views 21

Tulsa's New Spotlight: Gradient's CHROMA Event Well, look at Tulsa, becoming the center of the tech and enterprise universe for a day. Gradient is throwing open the doors for its second annual CHROMA event on September 24, 2026. You might scratch your head and say, ‘Tulsa? Really?’ But hear me out—this isn’t just a local shindig. We're talking about a one-day...

Continue Reading
SOPHiA GENETICS' Q3 2026: Revenue Growth & Challenges

Updated Category News Views 7

Unpacking SOPHiA GENETICS' Third Quarter Figures Let's cut through the jargon and get straight to the brass tacks. SOPHiA GENETICS (NASDAQ:SOPH) just posted their third quarter numbers for 2026, and it’s a mixed bag, my friends. Sure, they boasted a 25% bump in revenue, hitting $24.3 million, but the devil's in the details—net losses nudged up to $20.3 million, not...

Continue Reading
Marathon Petroleum's Massive Q3 2026 Profit Surge

Updated Category News Views 13

Marathon's Profit Skyrockets Marathon Petroleum Corp. (NYSE: MPC) just pulled off a Houdini act in the third quarter of 2026, as they reported a staggering net income of $7.4 billion. Compare that to last year's third quarter profits of $1.4 billion, and it's like comparing a sumo wrestler with a featherweight fighter. This transformation isn't just a fluke, it's a result...

Continue Reading
Newcomers, Veterans Elevate NYSE's Tokenization Efforts

Updated Category News Views 89

Breaking New Ground at the NYSE When the bell rings at the NYSE these days, it's not just marking the start of another trading session. It's the sound of change clanging its way onto Wall Street. On November 3, 2026, the NYSE threw its hat deeper into the tokenization ring, a game-changer perhaps. They've roped in some big guns—Securitize, tZERO, Broadridge Financial...

Continue Reading
Illumina's Role in Singapore's Precision Medicine Leap

Updated Category News Views 160

Singapore's Bold Step into Precision Medicine When it comes to revolutionizing healthcare, Singapore isn't content to sit on the sidelines. They've just thrown a serious hat into the ring with the SG-INSIGHT study, a cornerstone of their National Precision Medicine programme. And Illumina, Inc. (NASDAQ:ILMN) is right there in it, gearing up to sequence the genomes of...

Continue Reading

Top 5 Most Recently Viewed Articles

Rising Demand and Technological Advancements in Krill Meal Market

Updated Category News Views 226

Understanding the Expanding Krill Meal Market The krill meal market is undergoing remarkable growth, fueled by a shift in consumer preferences favoring clean-label food products and natural flavor enhancers. According to recent estimates, the market is poised to expand significantly, reaching an impressive valuation by the end of an upcoming decade. This growth can be...

Continue Reading
Tango Therapeutics Begins Dosing in Pivotal Cancer Trial

Updated Category News Views 224

Tango Therapeutics Begins Dosing in Pivotal Cancer Trial BOSTON — Tango Therapeutics, Inc. (NASDAQ: TNGX), a dynamic biotechnology company dedicated to revolutionizing cancer care, has achieved a pivotal milestone by dosing the first patient in its TNG456 Phase 1/2 trial aimed at patients with MTAP-deleted solid tumors, particularly glioblastoma (GBM). Known for its...

Continue Reading
Investors Invited to Explore Class Action against Rentokil Initial

Updated Category News Views 188

Investors Encouraged to Join Class Action Against Rentokil Initial Bronstein, Gewirtz & Grossman, LLC, a well-respected law firm known for its expertise in securities cases, is reaching out to investors of Rentokil Initial Plc. This communication centers around a class action lawsuit that has been filed on behalf of those affected by some significant events concerning the...

Continue Reading
Murphy USA's Dividend Boost: A Commitment to Shareholders

Updated Category News Views 78

Murphy USA's Dividend Boost Reflects Confidence in Growth Murphy USA Inc. (NYSE: MUSA), a well-known player in the gasoline and convenience store sector, has recently announced an increase in its quarterly cash dividend. The company's Board has declared a new dividend of $0.48 per share, which represents a notable 6.7% rise from the previous dividend. This increase...

Continue Reading
Cloudinary Enhances Digital Asset Management with New Features

Updated Category News Views 181

Cloudinary's Innovative Update to Digital Asset Management Today, Cloudinary, the leading image and video platform, revealed significant advancements in its API-first digital asset management (DAM) solution. These enhancements are designed to address the evolving needs of brands in managing their visual assets efficiently and effectively. With a focus on streamlining...

Continue Reading